» Authors » Wahid Doss

Wahid Doss

Explore the profile of Wahid Doss including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 54
Citations 440
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Fouad R, El-Akel W, ElMakhzangy H, Lithy R, Sherif M, Fateen M, et al.
Arab J Gastroenterol . 2025 Jan; 26(1):78-83. PMID: 39875290
Background And Study Aims: Hepatitis C virus (HCV) infection is a significant problem in Egypt, as it is associated with various hematological disorders, both benign and malignant. In Egypt, direct-acting...
2.
El-Kassas M, Elakel W, Elsharkawy A, Asem N, Abu-Elfatth A, Mostafa A, et al.
Sci Rep . 2024 Nov; 14(1):29544. PMID: 39604515
The continuous search for simple, noninvasive methods for assessing liver fibrosis remains very important to help risk-stratify and follow-up patients with chronic hepatitis C virus (HCV). This study aimed to...
3.
El-Sayed M, Elserafy M, Raziky M, Elakel W, Saad Y, Fayad T, et al.
Arab J Gastroenterol . 2023 Feb; 24(1):29-33. PMID: 36813580
Background And Study Aims: Hepatitis C virus (HCV) prevalence inchronic kidney disease (CKD) patients is significantly higher than in the general population. This study evaluated the efficacy and safety of...
4.
Gamal Eldeen H, Hassany M, Elakel W, Abdallah M, Abdel-Razek W, Elshazly Y, et al.
Arab J Gastroenterol . 2022 Nov; 23(4):259-262. PMID: 36336587
Background And Study Aims: Little is known about the true prevalence of hepatitis B virus (HBV) coinfection in patients with hepatitis C virus (HCV). This multicenter nationwide study aimed to...
5.
Kamal E, Asem N, Hassany M, Elshishiney G, Abdel-Razek W, Said H, et al.
Lancet Gastroenterol Hepatol . 2022 Apr; 7(7):658-665. PMID: 35489364
Until 2018, Egypt had the highest prevalence of hepatitis C virus (HCV) infection globally, affecting approximately 7% of the population. Despite efforts in diagnosis and treatment since 2006, nearly 2...
6.
El-Kassas M, Elakel W, Alboraie M, Ezzat R, Abdelhakam S, Hassany M, et al.
Arab J Gastroenterol . 2022 Apr; 23(2):120-124. PMID: 35473688
Background And Study Aims: In resource-limited countries, non-invasive tests for assessing liver fibrosis are a potential alternative to costly endoscopic screening for esophageal varices. We aimed to validate several non-invasive...
7.
Fouad Y, Esmat G, Elwakil R, Zakaria S, Yosry A, Waked I, et al.
Saudi J Gastroenterol . 2022 Jan; 28(1):3-20. PMID: 35083973
The landscape of chronic liver disease in Egypt has drastically changed over the past few decades. The prevalence of metabolic-associated fatty liver disease (MAFLD) has risen to alarming levels. Despite...
8.
Abdelaziz H, Omar H, Khalil M, Cordie A, Mohamed R, Abdallah M, et al.
Expert Rev Anti Infect Ther . 2021 Nov; 20(5):789-795. PMID: 34751609
Background: Liver disease has emerged as a leading cause of death among PLHIV coinfected with HCV. Methods: A retrospective study involving all HCV viremic patients coinfected with HIV who presented...
9.
Naguib G, Michael T, Elshazly Y, Wahdan M, Mostafa A, Ahmed O, et al.
Virusdisease . 2021 Oct; 32(3):582-588. PMID: 34631983
The aim of this study was to compare efficacy and safety of different combination regimens in re-treatment of HCV in the setting of inaccessibility of resistance testing. This real-life prospective...
10.
Elbaz T, Waked I, El-Akel W, Shaker M, Abdelaziz A, Yousif M, et al.
Expert Rev Anti Infect Ther . 2021 Jul; 20(2):307-314. PMID: 34253123
Background: There are many contradictory studies that dealt with hepatocellular carcinoma (HCC) recurrence rate of well ablated hepatitis C virus (HCV) related HCC. We aim to assess the recurrence rate...